Giving our people the space, time and resources to prepare for future pandemics
Building world-wide partnerships, data, infrastructure, technologies and discoveries to create global impact
Delivering novel treatments to improve the quality of life everywhere
We use cutting edge science and collaborative clinical practice to find, develop and test effective treatments at speed
We build on Edinburgh University’s expertise in genetics alongside cutting-edge drug delivery robotics, sensing technologies and clinical trial methodologies to accelerate discoveries and clinical translation in lung diseases.
Our ambition is to secure £100 million in investment and, through this funding, support collaborations with academic institutions, industry partners and global collaborators to drive interdisciplinary research and attract the best researchers to advance pandemic preparedness and treatment development.
The Baillie Gifford Pandemic Science Hub has been funded by a generous £14.7 million donation from Baillie Gifford and runs a multimillion-pound program that aims to develop innovative treatments for lung infections like Covid-19 and future pandemics.